Free Trial
NYSEAMERICAN:DXR

Daxor (DXR) Stock Price, News & Analysis

Daxor logo
$9.84 +0.09 (+0.87%)
As of 01:04 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Daxor Stock (NYSEAMERICAN:DXR)

Key Stats

Today's Range
$9.04
$9.88
50-Day Range
$7.20
$9.84
52-Week Range
$6.55
$10.00
Volume
4,920 shs
Average Volume
8,952 shs
Market Capitalization
$46.62 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive DXR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Daxor and its competitors with MarketBeat's FREE daily newsletter.

DXR Stock News Headlines

Daxor expands blood volume analysis technology across three networks
Daxor expands BVA services at Midwest healthcare facility
I was wrong about Trump
I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.
Daxor announces case series published in JACC
Daxor expands ezBVA Lab service to two new hospital systems
See More Headlines

DXR Stock Analysis - Frequently Asked Questions

Daxor's stock was trading at $7.9350 at the beginning of 2025. Since then, DXR shares have increased by 23.9% and is now trading at $9.8350.

Shares of DXR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Daxor investors own include Inovio Pharmaceuticals (INO), Pfizer (PFE), Gilead Sciences (GILD), Novavax (NVAX), iBio (IBIO), CRISPR Therapeutics (CRSP) and Dynavax Technologies (DVAX).

Company Calendar

Today
7/03/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSEAMERICAN
Sector
Medical
Industry
Medical Instruments & Supplies
Sub-Industry
Medical Equipment
Current Symbol
NYSEAMERICAN:DXR
Previous Symbol
NYSE:DXR
Employees
37
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
1,866,000
Market Cap
$46.62 million
Optionable
Not Optionable
Beta
-0.50
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (NYSEAMERICAN:DXR) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners